- Biden in historic Amazon trip as Trump return sparks climate fears
- India hails 'historic' hypersonic missile test flight
- Debt-saddled Laos struggles to tame rampant inflation
- India's vinyl revival finds its groove
- Climate finance can be hard sell, says aide to banks and PMs
- Egypt's middle class cuts costs as IMF-backed reforms take hold
- Dinosaur skeleton fetches 6 million euros in Paris sale
- Trump's Republican allies tread lightly on Paris pact at COP29
- China's Xi urges APEC unity in face of 'protectionism'
- Farmers target PM Starmer in protest against new UK tax rules
- UN climate chief urges G20 to spur tense COP29 negotiations
- Philippines warns of 'potentially catastrophic' Super Typhoon Man-yi
- Tens of thousands flee as Super Typhoon Man-yi nears Philippines
- Gabon votes on new constitution hailed by junta as 'turning point'
- Tens of thousands flee as Typhoon Man-yi nears Philippines
- Is Argentina's Milei on brink of leaving Paris climate accord?
- Fitch upgrades Argentina debt rating amid economic pain
- Trump picks Doug Burgum as energy czar in new administration
- At summit under Trump shadow, Xi and Biden signal turbulence ahead
- Xi warns against 'protectionism' at APEC summit under Trump cloud
- Xi, Biden at Asia-Pacific summit under Trump trade war cloud
- Leftist voices seek to be heard at Rio's G20 summit
- Boeing strike will hurt Ethiopian Airlines growth: CEO
- US retail sales lose steam in October after hurricanes
- Spate of child poisoning deaths sparks S.Africa xenophobia
- Comedian Conan O'Brien to host Oscars
- Gore says 'absurd' to hold UN climate talks in petrostates
- Global stocks struggle after Fed signals slower rate cuts
- China tests building Moon base with lunar soil bricks
- Oil execs work COP29 as NGOs slam lobbyist presence
- Gore says climate progress 'won't slow much' because of Trump
- 'Megaquake' warning hits Japan's growth
- Stiff business: Berlin startup will freeze your corpse for monthly fee
- Dominican Juan Luis Guerra triumphs at 25th annual Latin Grammys
- Tropical Storm Sara pounds Honduras with heavy rain
- TikTok makes AI driven ad tool available globally
- Japan growth slows as new PM readies stimulus
- China retail sales pick up speed, beat forecasts in October
- Pakistan's policies hazy as it fights smog
- Mexico City youth grapple with growing housing crisis
- Cracks deepen in Canada's pro-immigration 'consensus'
- Japan's Princess Mikasa, great aunt to emperor, dies aged 101
- Venezuela opposition activist dies in custody
- Policymakers defend Fed independence amid concerns about Trump era
- Lebanon economic losses top $5 billion in year of clashes: World Bank
- Fed Chair calls US the best-performing major economy in the world
- Brother of late Harrods owner also accused of sexual violence: BBC
- New York to revive driver congestion charge plan, drawing Trump ire
- China's Xi arrives in Peru for APEC summit, Biden meeting
- Spain's Vanguardia daily to stop posting on 'disinformation network' X
Nobel winner's ingenious chemistry could lead to cancer breakthroughs
"All kinds of crazy things" is how Carolyn Bertozzi, a 2022 Nobel laureate, describes her life's work. Actually performing "chemistry in cells and in people."
When she started her research in 1997, the Stanford professor was aiming only to observe the evolution of certain molecules on the surface of cancer cells.
Today, thanks to her discoveries, at least two companies -- including one she co-founded -- are developing innovative cancer treatments.
The multitude of applications made possible by her findings are impressive: delivering treatments with extreme precision, understanding better how drugs act inside the body, visualizing certain bacteria, to name a few.
"I can't even really enumerate them. The vast majority of those applications I would never have foreseen," she told AFP in an interview.
The Nobel Prize committee recognized Bertozzi's pioneering advances on Wednesday, making her only the eighth woman to win the chemistry prize, at just 55 years old.
- Lego pieces -
Her journey began when she found she had a passion for organic chemistry, while taking pre-medicine courses at Harvard.
The subject is notoriously -- many say fiendishly -- difficult, but she credits an "amazing professor," the late David Evans, for bringing it to life -- and changing the course of her life.
"I said, forget the med school thing. I'm going to be a chemist," said Bertozzi, whose sister is a professor of applied mathematics, and father a retired professor of physics.
After completing her post-doctorate and joining the faculty at UC Berkeley, she wanted to take a closer look at glycans: complex carbohydrates, or sugars, located on the surface of cells, which "go through structural changes" when they become cancerous.
At the time, "there was no tool to image sugars, like in a microscope, for example," she said.
She had an idea that would require two chemical substances that fit together perfectly, like pieces of lego.
The first lego is fed to cells via a sugar. The cell metabolizes it and places it on the tip of the glycan. The second piece of lego, a fluorescent molecule, is injected into the body.
The two lego pieces click together, and voila: hidden glycans reveal themselves under a microscope.
This technique is inspired by "click chemistry" developed independently by Denmark's Morten Meldal and American Barry Sharpless -- Bertozzi's co-winners. But their discoveries relied on using copper as a catalyst, which is toxic to the body.
One of Bertozzi's great leaps was achieving the same type of ultra-efficient reaction without copper.
The other tour de force: making it all happen without wreaking havoc with other processes in the body.
"The beauty of it is that you can take the two Legos and click them together, even if they're surrounded by millions of other very similar plastic toys," she explained.
She coined the term "bioorthogonal chemistry," meaning a reaction that doesn't interfere with other biochemical processes. Perfecting the technique took 10 years.
- 'Cycle of science' -
Researchers are now leveraging these breakthroughs to develop cancer treatments.
Glycans on cancer cells "are able to hide the cancer cell from the immune system -- and so your body can't fight it, it can't see it," she explains.
Using bioorthogonal chemistry, "we made a new type of medicine, which basically acts like a lawnmower," says Bertozzi.
The first lego attaches to the cancer cell's surface, and the second, which clips onto it, is equipped with an enzyme that "mows off the sugars as if they're just grass, it cuts the grass and the sugars fall off," she says with a smile.
The drug is currently being tested in the early stages of a clinical trial.
Another company is seeking to use bioorthogonal chemistry to better target cancer treatment. The first lego piece is injected into a tumor, then a second, which carries the drug, attaches itself and acts only on its target.
"So that allows the oncologist to treat the tumor and kill the tumor without exposing the person's entire body to a toxic chemical," she says.
"What the future holds is hopefully an impact in human health," says Bertozzi. "But the people who decide that more so than myself, are the students and postdocs that join my lab."
Hundreds of them, current and former, filled her email box with messages of congratulations this morning.
"That really is the cycle of science -- it's being mentored and then mentoring" she adds. And "mentoring students gives you an opportunity to amplify the impact of your science."
M.García--CPN